mTOR inhibitor augments the antitumor effect of p53-expressing oncolytic adenovirus in human neuroblastoma cells

被引：0
|
作者：
Tanimoto, Terutaka [1 ]
Tazawa, Hiroshi [1 ]
Noso, Hiroshi [1 ]
Tani, Morimichi [1 ]
Oyama, Takanori [1 ]
Urata, Yasuo [2 ]
Kagawa, Shunsuke [1 ]
Noda, Takuo [1 ]
Fujiwara, Toshiyoshi [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
[2] Oncolys Biopharma Inc, Okayama, Japan
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3177
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3177
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tumor suppressor p53 reactivation by oncolytic adenovirus reverses chemoresistance in human osteosarcomas
    Sugiu, Kazuhisa
    Tazawa, Hiroshi
    Hasei, Joe
    Osaki, Shuhei
    Yamakawa, Yasuaki
    Omori, Toshinori
    Komatsubara, Tadashi
    Uotani, Kouji
    Fujiwara, Tomohiro
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2016, 76
  • [42] Erratum: Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor
    A Carpentieri
    E Cozzoli
    M Scimeca
    E Bonanno
    A M Sardanelli
    A Gambacurta
    Cell Death & Disease, 2016, 7 : e2202 - e2202
  • [43] Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein
    Harris, MP
    Sutjipto, S
    Wills, KN
    Hancock, W
    Cornell, D
    Johnson, DE
    Gregory, RJ
    Shepard, HM
    Maneval, DC
    CANCER GENE THERAPY, 1996, 3 (02) : 121 - 130
  • [44] RECOMBINANT ADENOVIRUS EXPRESSING TAT-ANTI-HDM2 ENHANCES ANTITUMOR EFFECT WITH APOPTOSIS INDUCED BY P53 ACTIVATION
    Kim, Min-Ju
    Yoo, Ji Young
    Shin, Hye Won
    Kim, Joo-Hang
    Yun, Chae-Ok
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1187 - 1187
  • [45] Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7.1 in an Immuneocompetenet Mouse Model
    Yoo, Ji Young
    Lee, Young-Sook
    Kim, Jaesung
    Choi, Hyejin
    Kim, Joo-Hang
    Yun, Chae-Ok
    MOLECULAR THERAPY, 2006, 13 : S326 - S326
  • [46] Synergistic antitumor effects of CDK inhibitor SNS-032 and an oncolytic adenovirus co-expressing TRAIL and Smac in pancreatic cancer
    Ge, Yun
    Lei, Wen
    Ma, Yingyu
    Wang, Yigang
    Wei, Buyun
    Chen, Xiaoyi
    Ru, Guoqing
    He, Xianglei
    Mou, Xiaozhou
    Wang, Shibing
    MOLECULAR MEDICINE REPORTS, 2017, 15 (06) : 3521 - 3528
  • [47] Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells
    Fingrut, O
    Reischer, D
    Rotem, R
    Goldin, N
    Altboum, I
    Zan-Bar, I
    Flescher, E
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (06) : 800 - 808
  • [48] [6]-gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells
    Park, Yon Jung
    Wen, Jing
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    YONSEI MEDICAL JOURNAL, 2006, 47 (05) : 688 - 697
  • [49] RETRACTED: Ras Puts the Brake on Doxorubicin-mediated Cell Death in p53-expressing Cells (Retracted Article)
    Manna, Sunil K.
    Gangadharan, Charitha
    Edupalli, Damodar
    Raviprakash, Nune
    Navneetha, Thota
    Mahali, Sidharth
    Thoh, Maikho
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (09) : 7339 - 7347
  • [50] A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers
    Wang, Xinghua
    Su, Changqing
    Cao, Hui
    Li, Kui
    Chen, Jie
    Jiang, Lixin
    Zhang, Qi
    Wu, Xiaobing
    Jia, Xiaoyuan
    Liu, Yongjing
    Wang, Weiguo
    Liu, Xinyuan
    Wu, Mengchao
    Qian, Qijun
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (06) : 1598 - 1603
12345